Dabrafenib plus trametinib combination appears to be a promising treatment for patients with bile duct cancer (biliary tract cancer) with BRAF V600E mutations. Researchers reported these findings on August […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
